Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset Meeting Abstract
| Authors: | Italiano, A.; Drilon, A. E.; Shen, L.; Hong, D. S.; van Tilburg, C.; Tan, D. S. W.; Lin, J. J.; Kummar, S.; Doz, F.; Geoerger, B.; Brose, M. S.; Briggs, A.; Lassen, U. N.; Vassal, G.; Keating, K. N.; Norenberg, R.; Dima, L.; Brega, N.; Laetsch, T.; Garcia-Foncillas, J. |
| Abstract Title: | Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S752 |
| End Page: | S753 |
| Language: | English |
| ACCESSION: | WOS:000866211600458 |
| DOI: | 10.1016/j.annonc.2022.07.593 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 464P -- Source: Wos |
